Fidelity Select Medical Tech and Devcs holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Fidelity Select Medical Technology and Devices Portfolio FSMEX
- NAV / 1-Day Return $57.75 / +1.73 %
- Fund Size $3.6B
- Adjusted Expense Ratio 0.620%
- Net Expense Ratio 0.620%
- Fee Level: Distribution Low
- Share Class Type No Load
- Morningstar Category Health
- Equity Style Box (Funds) Mid Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 54%
Morningstar’s Analysis FSMEX
Will FSMEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 64.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Thermo Fisher Scientific Inc | 18.43 | 653M | Healthcare |
Danaher Corp | 13.62 | 483M | Healthcare |
Intuitive Surgical Inc | 5.51 | 195M | Healthcare |
West Pharmaceutical Services Inc | 4.48 | 159M | Healthcare |
Waters Corp | 4.46 | 158M | Healthcare |
10x Genomics Inc Ordinary Shares - Class A | 4.26 | 151M | Healthcare |
Agilent Technologies Inc | 4.23 | 150M | Healthcare |
Illumina Inc | 3.67 | 130M | Healthcare |
Natera Inc | 3.32 | 118M | Healthcare |
IQVIA Holdings Inc | 2.96 | 105M | Healthcare |